A study published in the journal Anesthesiology shows that opioids in a patient's body can enhance the malignant tendencies of cancer cells, regardless of further opioids being added, according to News & Research Outcomes Magazine.
The study, led by Patrick Singleton, PhD, adds evidence that mu opioid receptors in cancer cells influence cancer progression and spread. These receptors could become a therapeutic target for cancer treatment.
Dr. Singleton's findings also could influence surgical anesthesia used during cancer surgery.
More Articles on Anesthesia:
Anesthesia Machine Sales Expected to Increase by 2014
Dr. Brett Anderson Named Heritage Valley Chair of Anesthesiology
FDA Does Not Approve Zogenix's Zohydro Opioid Pain Medication
The study, led by Patrick Singleton, PhD, adds evidence that mu opioid receptors in cancer cells influence cancer progression and spread. These receptors could become a therapeutic target for cancer treatment.
Dr. Singleton's findings also could influence surgical anesthesia used during cancer surgery.
More Articles on Anesthesia:
Anesthesia Machine Sales Expected to Increase by 2014
Dr. Brett Anderson Named Heritage Valley Chair of Anesthesiology
FDA Does Not Approve Zogenix's Zohydro Opioid Pain Medication